Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
‘Christine Sun Kim: All Day All Night’ Review: Lines of Communication at the Whitney
The artist’s first museum survey pushes the bounds of language and upends notions about how we connect with one another.